Markets closed

AstraZeneca PLC Ordinary Shares

AZN · NYSE

Symbol: AZN
Type: Stock
Sector: Health Care
Industry: Pharmaceutical Preparations
Exchange: NYSE

AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide.

Key Issues

Bullish view

The Amgen-AstraZeneca IMDELLTRA-Imfinzi combination produced a survival benefit in a Phase 3 extensive-stage small-cell lung-cancer study, while AstraZeneca also reported a Phase III small-cell lung-cancer survival win. Those results support continued pipeline and franchise value.

Bearish view

A reported late-stage oncology trial miss caused after-hours weakness, and an executive was described as disappointed. Repeated setbacks could undermine confidence in the pipeline and keep valuation under pressure.